MD Anderson acquires inducible switch technologies for cell

MD Anderson has acquired certain assets from Bellicum Pharmaceuticals, Inc. related to the CaspaCIDE switch and GoCAR platforms. As a result, MD Anderson may in

Related Keywords

Houston , Texas , United States , University Of Texas , Philip Jones , Katy Rezvani , Bellicum Go , Bellicum Pharmaceuticals Inc , Drug Administration , Cancer Center , Research Strategy , Bellicum Pharmaceuticals , Therapeutics Discovery , Stem Cell Transplantation , Newswise , Ell Therapy Cancer Md Anderson Center , Cancer , Cell Biology , University Of Texas Md Anderson Cancer Center ,